Jeffrey A. Stafford
Therapeutics Clinical Research(US)Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Cancer Treatment and Pharmacology, Epigenetics and DNA Methylation, Cancer Mechanisms and Therapy, Cancer Cells and Metastasis
Most-Cited Works
- → Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity(2007)512 cited
- → Discovery of Alogliptin: A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV(2007)401 cited
- → CNS 7056(2007)388 cited
- → Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor(2008)342 cited
- → Daphniphyllum alkaloids. 14. Total synthesis of (.+-.)-bukittinggine(1992)139 cited
- → Discovery and Evaluation of 2-Anilino-5-aryloxazoles as a Novel Class of VEGFR2 Kinase Inhibitors(2005)135 cited